水凝胶敷料作为儿童急性热烧伤急救镇痛辅助手段的有效性:随机对照试验研究方案
本研究为随机对照试验方案,旨在评估Burnaid®水凝胶敷料作为冷水冲洗急救后镇痛辅助手段,对0-16岁急性热烧伤(总面积<20%)患儿的镇痛效果。主要结局为急性疼痛缓解,次要结局包括再上皮化天数、脉搏、体温、唾液皮质醇与α-淀粉酶、焦虑及成本效果。样本量计算每组招募36名参与者。
要点
- Burnaid®水凝胶作为儿童急性热烧伤急救镇痛的辅助手段,与塑料薄膜标准 practice 对比。
- 主要结局为急性疼痛缓解,次要结局包括再上皮化时间、生理指标、焦虑和成本效果。
- 高疼痛风险分层因素包括足部烧伤、热煤/灰/火坑烧伤、烧伤面积>5%及环形烧伤。
核心结论
- 该研究将评估Burnaid®水凝胶敷料作为冷水冲洗急救的镇痛辅助手段,能否有效减轻儿童急性热烧伤的疼痛并改善再上皮化时间。
研究设计与样本
- 随机对照试验,参与者为0-16岁、烧伤总面积<20%、烧伤后24小时内就诊于急诊科的急性热烧伤患儿,随机分为Burnaid®水凝胶组或塑料薄膜对照组,并按高/低疼痛风险分层,每组计划招募36名参与者。
关键数值与推荐
- 主要结局为干预对减轻急性疼痛的效果;次要结局包括再上皮化天数、脉搏率、体温、唾液皮质醇和α-淀粉酶、焦虑及成本效果。
- 高疼痛风险因素包括足部烧伤、热煤/灰/火坑烧伤、烧伤面积大于5%以及环形烧伤。
临床怎么用
- 若干预能有效减轻疼痛,Burnaid®将被整合为医院急诊科的标准实践。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Burns are a painful and traumatic experience, particularly in children. Reduced pain and anxiety positively influences re-epithelialisation rates in paediatric burn patients, however current literature fails to fully explain the effects of pain and anxiety and their links with wound healing. This study will determine if Burnaid® hydrogel dressing is an effective treatment for reducing pain in the acute period of a burn injury. It is hypothesised that a reduction in pain will then improve re-epithelialisation time in comparison to plastic wrap, which is standard practice at our institution - a metropolitan tertiary paediatric hospital located in Brisbane, Australia. METHODS/DESIGN: A randomised controlled trial will be conducted to assess the effectiveness of Burnaid® as an analgesic adjunct to cold running water first aid for the treatment of paediatric burns. Participants will include children aged between 0 and 16 years with an acute thermal burn injury (total burn surface area < 20%) presenting to the Department of Emergency within 24 h of the burn occurring. Participants will be randomised into one of two groups: (1) Burnaid® hydrogel (intervention arm) or (2) plastic wrap (control arm). Participants will also be stratified into one of two groups based on factors that influence pain intensity: (1) high pain risk or (2) low pain risk. High pain risk factors include foot burns, hot coal/ash/fire pit burns, burn area greater than 5%, and circumferential burns. The primary outcome is the intervention's effect on reducing acute pain. Secondary outcomes include days to re-epithelialisation, pulse rate, temperature, salivary cortisol and α-amylase, anxiety, and cost-effectiveness. Sample size calculations have shown that 36 participants will be recruited into each group. DISCUSSION: This study will provide comprehensive data on the analgesic properties of Burnaid® as an adjunct to first aid for the treatment of acute paediatric thermal burns. If the intervention is effective in reducing pain, Burnaid® will be integrated as standard practice within the hospital's Department of Emergency. This study replicates a real-world scenario in order to identify clinically significant analgesic and wound-healing effects. TRIAL REGISTRATION: Australian New Zealand Clinical Trials Registry, ACTRN12617001274369 . Prospectively registered on 5 Sept 2017.
引用
- Holbert MD, Griffin BR, McPhail SM, et al. Effectiveness of a hydrogel dressing as an analgesic adjunct to first aid for the treatment of acute paediatric thermal burn injuries: study protocol for a randomised controlled trial. Trials. 2019. PMID: 30612585. doi:10.1186/s13063-018-3057-x
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。